GENEVA--(BUSINESS WIRE)-- Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have been implanted worldwide.9,+ ...

Earnings call Alcon’s Q4 2025 sales rose 7% YoY to $2.7B, with core EPS of $0.78 and strong innovation-led growth across both Surgical and Vision Care. Management issued 2026 guidance for 5–7% sales ...

PanOptix delivers outstanding patient satisfaction and freedom from glasses; Vivity has a proven exceptionally low rate of visual disturbances 2-8,**,Δ,§,^,‡ Alcon is committed to furthering ...

Alcon agreed to buy LENSAR for $14.00/share cash, integrating ALLY, Streamline, and the legacy laser system to expand FLACS ...

Lensar (Nasdaq:LNSR) announced today that it reached an agreement with Alcon (NYSE:ALC) to terminate their planned merger.

Alcon AG reported its fourth-quarter 2025 financial results, showing steady growth with revenue of $2.7 billion, marking a 7% increase year-over-year. The earnings per share (EPS) stood at $0.78, ...

Lensar today entered into a priority credit line agreement in a move that analysts say casts doubt over its planned ...

Investing.com -- UBS reiterated a “buy” rating on Alcon Inc on Wednesday, naming the Swiss-headquartered eyecare company its top large-cap pick and setting a CHF95 price target, implying more than 50% ...

Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...